{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:43:52Z","timestamp":1791081832033,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1053\/j.seminhematol.2008.03.013","type":"journal-article","created":{"date-parts":[[2008,6,8]],"date-time":"2008-06-08T04:13:01Z","timestamp":1212898381000},"page":"S7-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S1","title":["Further Understanding of Recombinant Activated Factor VII Mode of Action"],"prefix":"10.1053","volume":"45","author":[{"given":"Dougald M.","family":"Monroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2008.03.013_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOH.0b013e3280dce57b","article-title":"Recombinant factor VIIa: Its background, development and clinical use","volume":"14","author":"Hedner","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0049-3848(90)90116-T","article-title":"Effect of recombinant human FVIIA on warfarin-induced bleeding in rats","volume":"59","author":"Diness","year":"1990","journal-title":"Thromb Res"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2008.03.013_bib3","first-page":"159","article-title":"Clinical experience with recombinant factor VIIa in patients with thrombocytopenia","volume":"26","author":"Kristensen","year":"1996","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jbiotec.2006.03.042","article-title":"Mechanism of action, development and clinical experience of recombinant FVIIa","volume":"124","author":"Hedner","year":"2006","journal-title":"J Biotechnol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/187152506778520745","article-title":"Novel therapeutic agents in the management of hemorrhage and thrombosis","volume":"4","author":"Kempton","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1538-7836.2007.02576.x","article-title":"Tissue factor around dermal vessels has bound factor VII in the absence of injury","volume":"5","author":"Hoffman","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2141.1984.tb06121.x","article-title":"The haemostatic plug in haemophilia A: A morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A","volume":"58","author":"Sixma","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib9","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/j.1538-7836.2005.01274.x","article-title":"Coated-platelets: An emerging component of the procoagulant response","volume":"3","author":"Dale","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib10","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2007.02389.x","article-title":"Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist","volume":"5","author":"Kjalke","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2141.2006.06178.x","article-title":"Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia","volume":"134","author":"Allen","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib14","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1046\/j.1538-7836.2003.00181.x","article-title":"How factor VIIa works in hemophilia","volume":"1","author":"Butenas","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2007.06534.x","article-title":"Factor VIIa analogue (V158D\/E296V\/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A","volume":"137","author":"S\u00f8rensen","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05820.x","article-title":"High dose factor VIIa improves clot structure and stability in a model of haemophilia B","volume":"131","author":"Wolberg","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1160\/TH05-07-0510","article-title":"Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors","volume":"95","author":"Kavakli","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","article-title":"Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors","volume":"2","author":"Abshire","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.TA.0000140646.66852.AB","article-title":"Factor VIIa for correction of traumatic coagulopathy","volume":"57","author":"Dutton","year":"2004","journal-title":"J Trauma"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/000313480507100509","article-title":"A Jehovah's Witness with complex abdominal trauma and coagulopathy: Use of factor VII and a review of the literature","volume":"71","author":"Haan","year":"2005","journal-title":"Am Surg"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF03022322","article-title":"The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference","volume":"54","author":"Karkouti","year":"2007","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","article-title":"Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey","volume":"2","author":"Poon","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1227\/01.NEU.0000068830.54968.A8","article-title":"Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients","volume":"53","author":"Park","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/00000542-200206000-00039","article-title":"Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children","volume":"96","author":"Tobias","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib27","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2004.01015.x","article-title":"Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets","volume":"2","author":"Gabriel","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.ATV.0000128125.80559.9c","article-title":"Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available","volume":"24","author":"Wielders","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/09537100400008059","article-title":"Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant factor VIIa","volume":"16","author":"Wegert","year":"2005","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1160\/TH03-10-0638","article-title":"The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation","volume":"91","author":"Gerotziafas","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1537-2995.2003.00427.x","article-title":"Increased local procoagulant action: A mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders","volume":"43","author":"Gal\u00e1n","year":"2003","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1538-7836.2005.01227.x","article-title":"Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count","volume":"3","author":"Lisman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MBC.0b013e328201c9a9","article-title":"Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography","volume":"18","author":"Young","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2008.03.013_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1538-7836.2003.00075.x","article-title":"Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation","volume":"1","author":"S\u00f8rensen","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"10.1053\/j.seminhematol.2008.03.013_bib35","article-title":"High dose factor VIIa corrects thrombin generation in a model of dilutional coagulopathy","volume":"5","author":"Stuckey","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719630800053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719630800053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:18:55Z","timestamp":1758521935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719630800053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":35,"alternative-id":["S003719630800053X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.03.013","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further Understanding of Recombinant Activated Factor VII Mode of Action","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}